Research Grants show all

NIH1

Patents show all

85Applications75Issued

SEC Filings show all

D2

SEC Form D Funding Events

DateOfferedSoldType
2014-08-27$4,000,000$299,879Equity
2006-01-04UnknownUnknownOther (Paper Filing)

Key Executives

  • Robert Gelfond
    Executive Officer, Director
  • Audrius Berzanskis
    Executive Officer